Published on: January 15, 2018 at 12:00PM Conditions: Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Blasts Under 10 Percent of...
Clinical Trials
Published on: January 12, 2018 at 12:00PM Conditions: Pancreatic Cancer; Liver Metastases; SurgeryInterventions: Procedure: Synchronous resection of primary...
Published on: January 12, 2018 at 12:00PM Conditions: Pancreatic Cancer; Liver Metastases; SurgeryInterventions: Procedure: Synchronous resection of primary...
Published on: January 12, 2018 at 12:00PM Condition: Peritoneal Metastases From Colorectal CancerInterventions: Procedure: exploratory laparoscopy or laparotomy; Procedure: HIPEC; Drug: Systemic chemotherapySponsor: Wuhan UniversityRecruiting http://ift.tt/2CWy5Jt
Published on: January 12, 2018 at 12:00PM Condition: Peritoneal Metastases From Colorectal CancerInterventions: Procedure: exploratory laparoscopy or laparotomy; Procedure: HIPEC; Drug: Systemic chemotherapySponsor: Wuhan UniversityRecruiting http://ift.tt/2CWy5Jt
Published on: January 12, 2018 at 12:00PM Condition: Peritoneal Metastases From Colorectal CancerInterventions: Procedure: exploratory laparoscopy or laparotomy; Procedure: HIPEC; Drug: Systemic chemotherapySponsor: Wuhan UniversityRecruiting http://ift.tt/2CWy5Jt
Published on: January 12, 2018 at 12:00PM Conditions: Gram-Negative Bacterial Infections; Pediatric Cancer; Colistin; Colistin Adverse Reaction; MICIntervention: Drug: ColistinSponsor:...
Published on: January 12, 2018 at 12:00PM Condition: Recurrent Platinum Resistant Ovarian CancerInterventions: Drug: VB-111 + Paclitaxel; Drug: PaclitaxelSponsors: Vascular Biogenics Ltd. operating as...
Published on: January 12, 2018 at 12:00PM Condition: Lung CancerIntervention: Sponsor: China-Japan Friendship HospitalRecruiting http://ift.tt/2DmSCIr
Published on: January 12, 2018 at 12:00PM Condition: Esophageal CancerIntervention: Device: BISSponsor: Samsung Medical CenterNot yet recruiting http://ift.tt/2CVm879
Published on: January 12, 2018 at 12:00PM Condition: Highly Endocrine Responsive Operable Breast CancerIntervention: Drug: Letrozole 2.5mgSponsor: Guangdong General HospitalCompleted http://ift.tt/2Doe53C
Published on: January 12, 2018 at 12:00PM Condition: Highly Endocrine Responsive Operable Breast CancerIntervention: Drug: Letrozole 2.5mgSponsor: Guangdong General HospitalCompleted http://ift.tt/2Doe53C
Published on: January 12, 2018 at 12:00PM Condition: Effectiveness of Health Education on Early Detection and Screening Tools of...
Published on: January 12, 2018 at 12:00PM Condition: Effectiveness of Health Education on Early Detection and Screening Tools of...
Published on: January 11, 2018 at 12:00PM Condition: CancerIntervention: Other: IMPROVED interventionSponsors: Massachusetts General Hospital; Alliance for Clinical Trials in...
Published on: January 11, 2018 at 12:00PM Condition: CancerIntervention: Other: IMPROVED interventionSponsors: Massachusetts General Hospital; Alliance for Clinical Trials in...
Published on: January 11, 2018 at 12:00PM Condition: Colorectal CancerIntervention: Drug: Apatinib + TegaserodSponsors: Henan Cancer Hospital; Jiangsu HengRui Medicine Co., Ltd.Recruiting http://ift.tt/2DlTXz5
Published on: January 11, 2018 at 12:00PM Condition: Colorectal CancerIntervention: Drug: Apatinib + TegaserodSponsors: Henan Cancer Hospital; Jiangsu HengRui Medicine Co., Ltd.Recruiting http://ift.tt/2DlTXz5
